Diagnostic Imaging Aid for Management of Cervical Lesions

Phase 2

• Conditions: Cervical Cancer; Digital Colposcopy; Cervical Intraepithelial Neoplasias; Precancerous Cervical Lesions
• Interventions: Device: Diagnostic imaging aid for one-visit management of cervical lesions

• Registration Number: NCT02406365
• Lead Sponsor: Brookdale University Hospital Medical Center

Brief Summary

A handheld digital colposcope which utilizes flurorescent light is being tested for the rapid detection and management of cervical lesions. The handheld research device captures cervical images which with the fluorescent light show the regions of cervical tissue that autofluoresce. The investigators will study the relationship between the level of fluorescence and the samples of tissue (biopsies) obtained from the patient as part of her routine care. The investigators will also compare the efficacy of the hand held device with the data being collected from the other research devices being tested by the team, i.e. the multispectral digital colposcopes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-03-17
• Study First Submitted QC: 2015-03-30
• Status Verified: 2015-04
• Study Start: 2015-04
• Study First Posted: 2015-04-02
• Last Update Submitted: 2015-04-09
• Last Update Posted: 2015-04-10
• Primary Completion: 2016-12
• Study Completion: 2017-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 618

Inclusion Criteria

• Women who are at least 18 years old
• Women who are not pregnant as confirmed by a urine test
• Women who are not breastfeeding
• Women who understand the study procedures and can provide written informed consent

Exclusion Criteria

• Women who do not meet the inclusion criteria
• Women who have had a hysterectomy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Standard of care plus imaging with research devices	Diagnostic imaging aid for one-visit management of cervical lesions	Eligible patients who consent to participate in the research study will receive their standard of care colposcopy or treatment with the Loop Electrosurgical Excision Procedure (LEEP). Additionally, cervical images will be taken using the diagnostic imaging aid. The cervical images will be compared to the histopathology from the biopsies taken as part of the patients' standard of care for colposcopy. If the patient is presenting for the LEEP procedure, then she will be asked if one or two biopsies can be obtained prior to the procedure but after anesthesia has been administered. The imaging device is not being used to make a diagnosis, but rather to develop an algorithm to make more efficacious and timely diagnoses of cervical neoplasias in the future.

Primary Outcome Measures

Name	Time	Method
Detection of precancerous cervical lesions or cervical cancer	At point of care for colposcopy or treatment with LEEP (5 minutes).	Eligible patients who are referred to the colposcopy clinic for a diagnosis following an abnormal Pap smear will be asked to participate in the study. All participating women will receive their standard of care colposcopy as usual. In addition to their routine care, the handheld imaging research device will also be used to capture cervical images. The images will be analyzed and compared to the biopsies obtained. The imaging device will not be used to make a diagnosis. As part of the research study, one or two additional biopsies will be obtained if the patient agrees. These additional biopsies will serve as the control tissue, since they will be taken from tissue that appears normal through the colposcope.

Trial Locations

Locations (1)

Brookdale University Hospital and Medical Center; 🇺🇸 Brooklyn, New York, United States